Catalog Number 121887654 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Pain (1994); Skin Irritation (2076)
|
Event Date 10/09/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Event Description
|
Subject id: (b)(6).Study: (b)(6).Clinical adverse event received for iliopsoas bursitis of left (study) hip event is not serious and is considered moderate event is not related to device and is related to procedure.Date of implantation: (b)(6) 2017.Date of event (onset): (b)(6) 2019 (left hip).Treatment: injection into iliopsoas bursa.Product details: component: summit stem porocoat std offset sz 6, catalog number: 157001120, lot number id: h33727.Component: ceramax ceramic insert neutral 54mm od 36mm id, catalog number: 121887654, lot number id: 849743.Component: pinnacle shell sector 54mm, catalog number: 121722054, lot number id: hc0470.Component: biolox delta femoral head ceramic 36mm +8.5, catalog number: 136536330, lot number id: 8550546.Component: cancellous bone screw 35mm, catalog number: 121735500, lot number id: d16091490.
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed, and the investigation will be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Search Alerts/Recalls
|
|